Global Advanced Wound Care Market Industry Trends and Forecast to 2024

Report Code: HC-R-17-10DB - 28 | Page Numbers: 0

Global Advanced Wound Care Market, By Type (Dressings, Biologics, Therapy Devices), By Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), By End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare), By Distribution Channel (Direct Tenders Public, Retail Private), By Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2024...

Buy Now

"Get Notified On all out New and Upcoming Reports"

       on all the latest research reports

Global Advanced Wound Care Market, By Type (Dressings, Biologics, Therapy Devices), By Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), By End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare), By Distribution Channel (Direct Tenders Public, Retail Private), By Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2024
1 Introduction
1.1. Overview of The Global Advanced Wound Care Market
1.2. Market Segmentation & Coverage
1.2.1. Currency and Pricing
1.2.2. Limitation
1.2.3 Stakeholders
2 Research Methodology
2.1. Key Takeaways
2.2. Arriving at The Advanced Wound Care Market Size
2.2.1. Market Crackdown Approach
2.2.2. Company Revenue and Market Share Analysis
2.2.3. Data Triangulation
2.2.4. Key Data Points from Primary Sources
2.2.5. Key Data Points from Secondary Sources
2.2.6. Porter's Five Forces Matrix
2.4. Global Advanced Wound Care Market: Research Snapshot
2.3. Assumptions
3 Market Landscape Summary
4 Premium Insights
4.1. Overview
4.2. Radiotherapy Market: Key Primary Insights
4.3. Market Overview
4.3.1. Drivers
4.3.1.1. Increasing Acceptance of Wound Care Biologics
4.3.1.2. Technologically Beneficial
4.3.1.3. Increasing Pool of Aging Population and Diabetes
4.3.1.4. Increasing Demand for Modern Healthcare In Asia
4.3.2. Restraints
4.3.3. Oppurtunities
4.3.4. Threats
4.4. Key Market Trends and Upcoming Technologies
5 Advanced Wound Care Market, By Type
5.1. Overview 5.2. Advanced Wound Care Dressings, By Product Type 5.2.1. Film Dressings
5.2.2. Foam Dressings
5.2.3. Hydrogels 5.2.4. Alginates
5.2.5. Wound Contact Layers
5.2.6. Super Absorbent Dressings 5.3. Advanced Wound Care Biologics, By Product Type
5.3.1. Allografts
5.3.2. Synthetic Skin Grafts 5.3.3. Xenografts
5.3.4. Growth Factors
5.3.4.1. Platelet-Derived Growth Factor (Pdgf)
5.3.4.2. Platelet Rich Plasma (Prp)
5.3.4.3. Epidermal Growth Factors (Egf)
5.3.4.4. Basic Fibroblast Growth Factor (Bfgf)
5.3.4.5. Granulocyte-Colony Stimulating Factor (G-Csf) 5.3.4.6. Talactoferrin Alfa
5.3.4.6. Thrombin Peptide (Tp508)
5.3.4.6. Keratinocyte Growth Factor (Kgf)
5.4. Advanced Wound Care Therapy Devices, By Product Type
5.4.1. Negative Pressure Wound Therapy Devices (Npwt)
5.4.1.1. Stand-Alone Npwt Devices
5.4.1.2. Portable Npwt Devices
5.4.1.3. Disposable Npwt Devices
5.4.2. Pressure Relief Devices (Prd)
5.4.2.1. Matresses
5.4.2.2. Beds
5.4.3. Hyberbaric Oxygen Chambers
5.4.3.1. Monoplace
5.4.3.2. Multiplace
5.4.3.3. Topical 5.4.4. Wound Debridement Devices
5.4.4.1. Hydrosurgical
5.4.4.2. Mechanical
5.4.4.3. Ultrasound
5.4.4.4. Others
5.4.5. Physical Therapies
5.4.5.1. Laser Therapy
5.4.5.2. Electrical Stimulation
5.4.5.3. External Shock Wave Therapies (Eswt)
5.4.5.4. Saline Mist Therapy
6 Advanced Wound Care Market, By Wound Type
6.1. Overview
6.2. Surgical Wounds
6.3. Diabetic Ulcers
6.4. Pressure Ulcers
6.5. Venous Ulcers
6.6. Burns
6.7. Others
7 Advanced Wound Care Market, By End-User
7.1. Overview
7.2. Hospitals
7.3. Wound Care Centers
7.4. Ambulatory Centers
7.5. Home Healthcare
7.6. Clinics
7.7. Community Healthcare
8 Advanced Wound Care Market, By Distribution Channel
8.1. Overview
8.2. Direct Tenders
8.3. Retail
9 Advanced Woundcare Market, By Geography
9.1. Countrywise Advanced Wound Care Market, (All Segmentation Provided Above Is Represented In This Chapter By Country)
9.1.1. North America
9.1.1.1. U.S.
9.1.1.2. Canada
9.1.1.3. Mexico
9.1.2. Europe
9.1.2.1. Germany
9.1.2.2. France
9.1.2.3. U.K.
9.1.2.4. Italy
9.1.2.5. Spain
9.1.2.6. Russia
9.1.2.7. Turkey
9.1.2.8. Belgium
9.1.2.9. Netherlands
9.1.2.10. Switzerland
9.1.2.11. Rest of Europe
9.1.3. Asia-Pacific (APAC)
9.1.3.1. Japan
9.1.3.2. China
9.1.3.3. South Korea
9.1.3.4. India
9.1.3.5. Australia
9.1.3.6. Singapore
9.1.3.7. Thailand
9.1.3.8. Malaysia
9.1.3.9. Indonesia
9.1.3.10. Philippines
9.1.3.11. Rest of APAC
9.1.4. Latin America
9.1.4.1. Brazil
9.1.4.2. Rest of Latin America
9.1.5. Middle East and Africa
9.1.5.1. South Africa
9.1.5.2. Rest of Middle East and Africa
9.2. Key Primary Insights: By Major Countries
10 Advanced Wound Care Market:Competitve Landscape
10.1. Global Advanced Wound Care Market: Company Share Analysis
10.2. U.S. Advanced Wound Care Market: Company Share Analysis
10.3. Europe Advanced Wound Care Market: Company Share Analysis
10.4. APAC Advanced Wound Care Market: Company Share Analysis
10.5. South America Advanced Wound Care Market: Company Share Analysis
10.6. Mea Advanced Wound Care Market: Company Share Analysis
10.7. Mergers & Acquisitions
10.8. New Product Development & Approvals
10.9. Expansions
10.10. Regulatory Changes
10.11. Partnership and Other Strategic Developments
11 Advanced Wound Care Market, Company Profiles
11.1 3m
11.1.1 Company Overview
11.1.2 Swot Analysis
11.1.3 Revenue Analysis
11.1.4 Product Portfolio
11.1.5 Recent Developements
11.1.5 Data Bridge Analysis
11.2 Smith and Nephew
11.2.1 Company Overview
11.2.2 Swot Analysis
11.2.3 Revenue Analysis
11.2.4 Product Portfolio
11.2.5 Recent Developements
11.2.6 Data Bridge Analysis
11.3 Medtronic
11.3.1 Company Overview
11.3.2 Swot Analysis
11.3.3 Revenue Analysis
11.3.4 Product Portfolio
11.3.5 Recent Developements
11.3.5 Data Bridge Analysis
11.4 Acelity L.P. Inc.
11.4.1 Company Overview
11.4.2 Swot Analysis
11.4.3 Revenue Analysis
11.4.4 Product Portfolio
11.4.5 Recent Developements
11.4.5 Data Bridge Analysis
11.5 Becton, Dickinson And Company
11.5.1 Company Overview
11.5.2 Swot Analysis
11.5.3 Revenue Analysis
11.5.4 Product Portfolio
11.5.5 Recent Developements
11.5.5 Data Bridge Analysis
11.6 Molyncke Health Care Ab
11.6.1 Company Overview
11.6.2 Swot Analysis
11.6.3 Revenue Analysis
11.6.4 Product Portfolio
11.6.5 Recent Developements
11.6.5 Data Bridge Analysis
11.7 Convatec Inc.
11.7.1 Company Overview
11.7.2 Swot Analysis
11.7.3 Revenue Analysis
11.7.4 Product Portfolio
11.7.5 Recent Developements
11.7.5 Data Bridge Analysis
11.8 Baxter
11.8.1 Company Overview
11.8.2 Swot Analysis
11.8.3 Revenue Analysis
11.8.4 Product Portfolio
11.8.5 Recent Developements
11.8.5 Data Bridge Analysis
11.9 Coloplast
11.9.1 Company Overview
11.9.2 Swot Analysis
11.9.3 Revenue Analysis
11.9.4 Product Portfolio
11.9.5 Recent Developements
11.9.5 Data Bridge Analysis
11.9 Ethicon, Inc. (A Johnson And Johnson Company)
11.9.1 Company Overview
11.9.2 Swot Analysis
11.9.3 Revenue Analysis
11.9.4 Product Portfolio
11.9.5 Recent Developements
11.9.5 Data Bridge Analysis
11.9 Hollister Incorporated
11.9.1 Company Overview
11.9.2 Swot Analysis
11.9.3 Revenue Analysis
11.9.4 Product Portfolio
11.9.5 Recent Developements
11.9.5 Data Bridge Analysis
11.10 Integra Lifesciences Corporation
11.10.1 Company Overview
11.10.2 Swot Analysis
11.10.3 Revenue Analysis
11.10.4 Product Portfolio
11.10.5 Recent Developements
11.10.5 Data Bridge Analysis
11.11 Derma Sciences Inc.
11.11.1 Company Overview
11.11.2 Swot Analysis
11.11.3 Revenue Analysis
11.11.4 Product Portfolio
11.11.5 Recent Developements
11.11.5 Data Bridge Analysis
11.12 Spiracur, Inc.
11.12.1 Company Overview
11.12.2 Swot Analysis
11.12.3 Revenue Analysis
11.12.4 Product Portfolio
11.12.5 Recent Developements
11.12.5 Data Bridge Analysis
11.13 Medline Industries
11.13.1 Company Overview
11.13.2 Swot Analysis
11.13.3 Revenue Analysis
11.13.4 Product Portfolio
11.13.5 Recent Developements
11.13.5 Data Bridge Analysis
11.14 Mimedx Group
11.14.1 Company Overview
11.14.2 Swot Analysis
11.14.3 Revenue Analysis
11.14.4 Product Portfolio
11.14.5 Recent Developements
11.14.5 Data Bridge Analysis
11.15 Organogenesis, Inc.
11.15.1 Company Overview
11.15.2 Swot Analysis
11.15.3 Revenue Analysis
11.15.4 Product Portfolio
11.15.5 Recent Developements
11.15.5 Data Bridge Analysis
11.16 Talley Group
11.16.1 Company Overview
11.16.2 Swot Analysis
11.16.3 Revenue Analysis
11.16.4 Product Portfolio
11.16.5 Recent Developements
11.16.5 Data Bridge Analysis
11.17 Bsn Medical
11.17.1 Company Overview
11.17.2 Swot Analysis
11.17.3 Revenue Analysis
11.17.4 Product Portfolio
11.17.5 Recent Developements
11.17.5 Data Bridge Analysis
11.18 Devon Medical Products
11.18.1 Company Overview
11.18.2 Swot Analysis
11.18.3 Revenue Analysis
11.18.4 Product Portfolio
11.18.5 Recent Developements
11.18.5 Data Bridge Analysis
11.19 Human Biosciences, Inc.
11.19.1 Company Overview
11.19.2 Swot Analysis
11.19.3 Revenue Analysis
11.19.4 Product Portfolio
11.19.5 Recent Developements
11.19.5 Data Bridge Analysis
11.20 B.Braun Melsungen Ag
11.20.1 Company Overview
11.20.2 Swot Analysis
11.20.3 Revenue Analysis
11.20.4 Product Portfolio
11.20.5 Recent Developements
11.20.5 Data Bridge Analysis
11.21 Cardinal Health
11.21.1 Company Overview
11.21.2 Swot Analysis
11.21.3 Revenue Analysis
11.21.4 Product Portfolio
11.21.5 Recent Developements
11.21.5 Data Bridge Analysis
11.22 Paul Hartmann Limited
11.22.1 Company Overview
11.22.2 Swot Analysis
11.22.3 Revenue Analysis
11.22.4 Product Portfolio
11.22.5 Recent Developments
11.22.5 Data Bridge Analysis
12 Appendix
12.1. Epidemiology Data
12.2. Sources and Bibliography 12.3. Related Reports
12.4. A Glimse Of Data Bridge Market Research Factbook
13 About Data Bridge Market Research
Synopsis:

Global advanced wound care market is expected to reach USD 20.7 billion by 2024 from USD 11.6 billion in 2016, at a CAGR of 7.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.


Wound care management is a growing field that has been witnessing a number of technological advancements in recent years. There are various products available in the market which has made treatment of wounds easier. The companies operating in the global advanced wound care market are focusing on incorporating advanced and innovative features in their products to differentiate them from other products available in the market. Companies operating in this market are focusing on acquisitions to strengthen their product portfolio and enhance their market position.


The Global Advanced Wound Care Market has been segmented on the basis of type the market is segmented into on the basis of type the advanced wound care market is segmented into dressings, biologics and therapy devices. The advanced wound care dressings market is further segmented on the basis of product type into foam dressings, film dressings, hydrogels, alginates, wound contact layers and super absorbent dressings. The advanced wound care biologics market segment is sub-segment into allografts, synthetic skin grafts, xenografts, and growth factors. The Therapy devices segment is further classified on the basis of product type into NPWT devices, pressure relief devices, hyperbaric oxygen chambers (HBOT), wound debridement devices and physical therapies.


Based on end users, the market is segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.


The global Advanced Wound Care market is segmented into geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. These regions are further classified on the basis of country, into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.


Major Players Operating in this market:

3M, Smith and Nephew, Medtronic, Acelity L.P., Inc., Becton Dickinson and Company, Molyncke Healthcare AB, Convatec, Inc., Baxter, Coloplast, Ethicon, Inc., Hollister Incorporated, Integra Lifesciences Corporation, Derma Sciences, Inc., Spiracur, Inc., Medline Industries, Mimedx, Inc., Organogenesis, Inc., Talley Group, BSN Medical, Devon Medical Products, Human Biosciences, Inc., Cardinal Health, B.Braun Melsungen AG and Paul Hartmann Limited among others.

Regions Covered in The Scope of The Report:

Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America),Middle East and Africa)).

Download Sample

Just fill the short form below to get the sample

Don’t like forms? Give us a call. U.S. +1(973)805-7440 (International) Email us at: amit@ceskaa.com